Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: principles and applications to hematopoietic cells.

V F Van Tendeloo1, C Van Broeckhoven, Z N Berneman

  • 1Laboratory of Experimental Hematology, University of Antwerp, Antwerp University Hospital, Belgium.

Leukemia
|May 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Diagnostic Testing in Charcot-Marie-Tooth Disease and Related Disorders: Approaches and Results.

Annals of the New York Academy of Sciences·2017
Same author

A Second Family with Autosomal Dominant Burning Feet Syndrome.

Annals of the New York Academy of Sciences·2017
Same author

Distal Hereditary Motor Neuropathy Type II (Distal HMN Type II): Phenotype and Molecular Genetics.

Annals of the New York Academy of Sciences·2017
Same author

Mutation Screening of Charcot-Marie-Tooth Patients in Poland.

Annals of the New York Academy of Sciences·2017
Same author

Hereditary Neuralgic Amyotrophy: Mutation Analysis of Candidate Genes.

Annals of the New York Academy of Sciences·2017
Same author

Preimplantation Diagnosis for Charcot-Marie-Tooth Type 1A.

Annals of the New York Academy of Sciences·2017

Gene therapy aims to treat diseases by transferring genes into hematopoietic cells. Overcoming challenges in gene delivery and expression is key to realizing its full potential for inherited and acquired conditions.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Hematology

Background:

  • The hematopoietic system is a primary target for gene therapy due to its role in inherited and acquired diseases.
  • Gene therapy has seen significant advancements and clinical applications over the past decade.
  • Efficient gene transfer and sustained transgene expression are critical for therapeutic success.

Purpose of the Study:

  • To review current gene delivery technologies for human somatic cells.
  • To discuss the significance of the hematopoietic system in gene therapy strategies.
  • To explore hematopoietic cell-based gene therapy approaches.

Main Methods:

  • Overview of existing gene delivery technologies for somatic cells.
  • Analysis of retroviral vectors and their limitations in hematopoietic cell gene transfer.

Related Experiment Videos

  • Discussion of conceptual and technical hurdles in gene therapy.

    • Main Results:

    • Retroviral vectors are widely used but have limitations for hematopoietic cell gene transfer.
    • Advancements in gene transfer efficiency and expression are expanding therapeutic possibilities.
    • Challenges in delivery and expression remain significant obstacles.

    Conclusions:

    • Efficient gene transfer and expression are paramount for successful gene therapy.
    • Further research is needed to overcome current technical hurdles.
    • Gene therapy holds promise for treating a wider range of diseases affecting the hematopoietic system.